ClinicalTrials.Veeva

Menu

Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function (GLIMPSE-LION)

Oregon Health & Science University (OHSU) logo

Oregon Health & Science University (OHSU)

Status

Enrolling

Conditions

Inflammation
Brain Injuries, Traumatic
Phototherapy
Glymphatic System
Mitochondrial Dynamics
Sleep

Treatments

Device: Negative Ion Generator Therapy
Device: Morning Bright Light Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT07601841
TP240626 (Other Grant/Funding Number)
STUDY00028579

Details and patient eligibility

About

This is a clinical trial designed to examine how improved sleep through morning bright light therapy is improving downstream key physiologic processes related to brain health, i.e., mitochondrial function, systemic inflammation, and glymphatic function. All proposed methodology is already approved in other IRB applications.

Enrollment

300 estimated patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

All subjects must:

  1. Male and female; any race; 18-89 years of age.

  2. Be English speaking.*

  3. Be accessible via phone.

  4. Be non-decisionally impaired. Determined by assessing the subject's ability to verbalize their understanding of the protocol back to us during the informed consent process.

  5. Not have a history of macular degeneration.

  6. Not have a history of bipolar disorder.

  7. Not be currently using a lightbox or a negative ion generator.

  8. Not be a shift worker.

  9. Have a documented history of TBI via the Head Trauma Events Characteristics (HTEC) or OHIO conducted in accordance with VA/DoD Clinical Practice Guidelines.88

  10. Present with self-reported sleep-wake disturbances.

  11. Remain clinically stable for current pharmacologic treatment related to depression/anxiety, sleep, and pain.

  12. MRI specific compatibility requirements:

    • No pacemaker, wires, defribrillator or implanted heart valves

    • No history of head surgery requiring aneurysm clips

    • No history of other orthopedic or general surgery requiring the implantation of ferrous pins, joints, electric devices/pumps, or other foreign metal objects

    • History of eye exposure to metal (unprotected welding/metalworking/shrapnel) is allowable provided the participant screens negative for metal in the eyes on an orbital x-ray or is able to provide clinical documentation of having screened negative.

    • No history of non-removable hearing aids, middle/inner ear prosthesis, or dentures

    • No history of claustrophobia; if unsure participant will be pre-screened in our mock scanner

    • Not currently pregnant, breastfeeding, or have an implanted IUD. Participants who are unsure of their pregnancy status will be administered an hCG urine pregnancy test the day of their scan.

    • Able to lay flat on their back comfortably without a thick pillow for an extended period of time.

    • Shoulder width does not exceed width for safety fitting in the MRI bore.

      • This study is limited to English-speaking participants because all assessments, interventions, and consent materials are currently validated and approved only in English. Expanding to other languages would require translation and psychometric validation, which are beyond the scope and budget of this study. This limitation is acknowledged and will be addressed in future research as resources permit. Finally, the study team is only fluent in English, making it infeasible to accurately consent or interact with non-English speakers without interpreting services which again is outside of the scope of this projects budget and timeline. Proceeding without formal translation services would risk miscommunication in informed consent, data collection, or participant support and thus protects participants informed consent and participant understanding.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

300 participants in 2 patient groups

Morning Bright Light Therapy
Experimental group
Description:
Exposure to bright light in the morning every day for an hour for 4 weeks.
Treatment:
Device: Morning Bright Light Therapy
Negative Ion Generator Therapy
Other group
Description:
Exposure to negative ions in the morning every day for an hour for 4 weeks.
Treatment:
Device: Negative Ion Generator Therapy

Trial contacts and locations

1

Loading...

Central trial contact

Jonathan Elliott, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems